Assignee
LIXTE BIOTECHNOLOGY INC
US·18 granted patents·6 pending applications·137 citations·filing 2008–2024
Top patents by PatentIndex Score
24 records- 0198US11236102B2Oxabicycloheptane prodrugsLIXTE BIOTECHNOLOGY INC·Filed 2020·Granted Feb 1, 2022·5 cites·9 claims
- 0296US10618908B2Oxabicycloheptane prodrugsLIXTE BIOTECHNOLOGY INC·Filed 2019·Granted Apr 14, 2020·6 cites·11 claims
- 0396US7998957B2Oxabicycloheptanes and oxabicylcoheptenes, their preparation and useLIXTE BIOTECHNOLOGY INC·Filed 2008·Granted Aug 16, 2011·39 cites·30 claims
- 0495US10364252B2Oxabicycloheptane prodrugsLIXTE BIOTECHNOLOGY INC·Filed 2018·Granted Jul 30, 2019·7 cites·19 claims
- 0595US9988394B2Oxabicycloheptane prodrugsLIXTE BIOTECHNOLOGY INC·Filed 2016·Granted Jun 5, 2018·7 cites·16 claims
- 0693US10668062B2Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetesLIXTE BIOTECHNOLOGY INC·Filed 2018·Granted Jun 2, 2020·5 cites·20 claims
- 0793US9079917B2Oxabicycloheptanes and oxabicycloheptenes, their preparation and useLIXTE BIOTECHNOLOGY INC·Filed 2014·Granted Jul 14, 2015·17 cites·26 claims
- 0893US8822461B2Oxabicycloheptanes and oxabicycloheptenes, their preparation and useLIXTE BIOTECHNOLOGY INC·Filed 2013·Granted Sep 2, 2014·16 cites·20 claims
- 0992US11866444B2Oxabicycloheptane prodrugsLIXTE BIOTECHNOLOGY INC·Filed 2022·Granted Jan 9, 2024·1 cites·10 claims
- 1091US10023587B2Oxabicycloheptanes and oxabicycloheptenes, their preparation and useLIXTE BIOTECHNOLOGY INC·Filed 2017·Granted Jul 17, 2018·6 cites·3 claims
- 1189US10399993B2Oxabicycloheptanes and oxabicycloheptenes, their preparation and useLIXTE BIOTECHNOLOGY INC·Filed 2018·Granted Sep 3, 2019·5 cites·14 claims
- 1289US10149847B2Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetesLIXTE BIOTECHNOLOGY INC·Filed 2013·Granted Dec 11, 2018·6 cites·20 claims
- 1386US10413541B2Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disordersLIXTE BIOTECHNOLOGY INC·Filed 2017·Granted Sep 17, 2019·5 cites·20 claims
- 1485US9994584B2Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acidLIXTE BIOTECHNOLOGY INC·Filed 2015·Granted Jun 12, 2018·6 cites·2 claims
- 1581US11931354B2Formulations of oxabicycloheptanes and oxabicycloheptenesLIXTE BIOTECHNOLOGY INC·Filed 2019·Granted Mar 19, 2024·1 cites·4 claims
- 1679US10532050B2Formulations of oxabicycloheptanes and oxabicycloheptenesLIXTE BIOTECHNOLOGY INC·Filed 2014·Granted Jan 14, 2020·5 cites·12 claims
- 1778US12343342B2Methods for treating soft tissue sarcomaLIXTE BIOTECHNOLOGY INC·Filed 2023·Granted Jul 1, 2025·0 cites·5 claims
- 1866US2025221985A1Oxabicycloheptanes for Modulation of Immune ResponseLIXTE BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 1961US2023310418A1Compositions and methods for treating cancer or preventing, inhibiting or reducing risk of metastasis of a cancerLIXTE BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 2058US2023065158A1Oxabicycloheptanes for treatment of small cell lung cancerLIXTE BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2153US12168008B2Oxabicycloheptanes for modulation of immune responseLIXTE BIOTECHNOLOGY INC·Filed 2017·Granted Dec 17, 2024·0 cites·35 claims
- 2253US2019111053A1Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitorLIXTE BIOTECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 2351US2021275521A1Oxabicycloheptanes for treatment of secondary acute myeloid leukemiaLIXTE BIOTECHNOLOGY INC·Filed 2018·Application pending·0 cites
- 2451US2021379106A1Oxabicycloheptanes for enhancing car t cell functionLIXTE BIOTECHNOLOGY INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LIXTE BIOTECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →